These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 526773)

  • 1. The distribution and irreversible tissue binding of practolol and its metabolites in the hamster [proceedings].
    Lindup WE; Longshaw S; Orton TC; Whittaker SE
    Br J Pharmacol; 1979 Jul; 66(3):504P. PubMed ID: 526773
    [No Abstract]   [Full Text] [Related]  

  • 2. Irreversible protein binding of [14C]-practolol metabolite(s) to hamster liver microsomes (proceedings).
    Orton TC; Lowery C; Lindup WE
    Br J Pharmacol; 1977 Jun; 60(2):319P. PubMed ID: 880481
    [No Abstract]   [Full Text] [Related]  

  • 3. Practolol metabolism. III. Irreversible binding of [14C]practolol metabolite(s) to mammalian liver microsomes.
    Orton TC; Lowery C
    J Pharmacol Exp Ther; 1981 Oct; 219(1):207-12. PubMed ID: 6793710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practolol and its metabolites: tissue localization and retention in the hamster.
    Rosenbaum SE; Lindup WE; Orton TC
    J Pharmacol Exp Ther; 1985 Aug; 234(2):485-90. PubMed ID: 4020682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practolol: aspects of its metabolism and ocular binding in the hamster.
    Rosenbaum SE; Lindup WE; Orton TC
    Xenobiotica; 1986 Jun; 16(6):567-73. PubMed ID: 3751112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism studies with practolol [proceedings].
    Case DE; Lindup WE; Lowery C; Orton TC; Reeves PR; Whittaker SE
    Br J Pharmacol; 1978 Jun; 63(2):352P. PubMed ID: 96899
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Overflow of (14C)-practolol and (14C)-racemic propranolol from the isolated rat vas deferens.
    Lewis MJ; Graham JD
    Br J Pharmacol; 1974 Sep; 52(1):125P. PubMed ID: 4451780
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: An investigation of the rat in situ absorption model using practolol and propranolol.
    Taylor DC; Grundy RU
    J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():65P. PubMed ID: 2741
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings: The renal clearnace of practolol in man.
    Tilstone WJ; Semple PF; Boyle JA
    J Pharm Pharmacol; 1974 Dec; 26 Suppl():66P-67P. PubMed ID: 4156746
    [No Abstract]   [Full Text] [Related]  

  • 10. Absorption of practolol and propranolol in dog intestinal loops in situ [proceedings].
    Taylor DC; Grundy RU; Loveday BE
    J Pharm Pharmacol; 1977 Dec; 29 Suppl():51P. PubMed ID: 22683
    [No Abstract]   [Full Text] [Related]  

  • 11. Does ampicillin affect practolol kinetics? [proceedings].
    Kelly JG; Leahey WJ; McDevitt DG; Riddell JG
    Br J Clin Pharmacol; 1977 Jun; 4(3):396P. PubMed ID: 901722
    [No Abstract]   [Full Text] [Related]  

  • 12. [Elimination of practolol in uremia].
    Wierzchowiecki M; Michałowska D; Tomaszkiewicz T; Maćkowiak M; Ochotny R
    Wiad Lek; 1980 May; 33(9):677-81. PubMed ID: 7405235
    [No Abstract]   [Full Text] [Related]  

  • 13. Biliary excretion and enterohepatic recirculation of practolol in man.
    Carruthers SG; Kelly JG; Johnson GW; McDevitt DG
    Ir J Med Sci; 1976 Jun; 145(6):187-94. PubMed ID: 939682
    [No Abstract]   [Full Text] [Related]  

  • 14. A study of practolol elimination in all grades of chronic renal failure.
    Kaye CM; Kumana CR; Franklin DA; Baker LR
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):83-8. PubMed ID: 1165145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practolol metabolism. II. Metabolism in human subjects.
    Reeves PR; Case DE; Jepson HT; McCormick DJ; Nicholls JT; Felix RH; Holt PJ; Zacharias FJ; Fluke RW
    J Pharmacol Exp Ther; 1978 May; 205(2):489-98. PubMed ID: 641844
    [No Abstract]   [Full Text] [Related]  

  • 16. The elimination of practolol by two human subjects.
    Dring LG; Gorchein A; Mahgoub AA; Smith RL
    Br J Clin Pharmacol; 1978 Mar; 5(3):262-5. PubMed ID: 148896
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of alpha-naphthoflavone on the metabolism and binding of ethinylestradiol in male Syrian hamster liver microsomes: possible role in hepatocarcinogenesis.
    Haaf H; Metzler M; Li JJ
    Cancer Res; 1988 Oct; 48(19):5460-5. PubMed ID: 3416302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha 2-adrenergic receptor turnover in adipose tissue and kidney: irreversible blockade of alpha 2-adrenergic receptors by benextramine.
    Taouis M; Berlan M; Lafontan M
    Mol Pharmacol; 1987 Jan; 31(1):89-96. PubMed ID: 2880286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo distribution & action of emetine on protein synthesis in hamster tissues.
    Agarwal S; Dube P; Sagar P
    Indian J Exp Biol; 1983 Jun; 21(6):353-4. PubMed ID: 6667991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.